Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INSR | P06213 | 13/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13294099 | 0.79 | SNCA (0.43) | INSR | |
| SCHEMBL13294128 | 0.79 | INSR (0.50) | INSRMAPTRAB9ANPC1KMT2A | |
| SCHEMBL13294121 | 0.73 | INSR (0.52) | INSRMAPTRAB9ANPC1KMT2A | |
| SCHEMBL16549701 | 0.72 | GAA (0.44) | MAPTRAB9AALDH1A1MEN1NPC1 | |
| Hydrochloric Acid SCHEMBL16538956 | 0.71 | GAA (0.43) | MAPTRAB9AALDH1A1MEN1NPC1 | |
| Hydrochloric Acid SCHEMBL16538959 | 0.71 | GAA (0.43) | MAPTRAB9AALDH1A1MEN1NPC1 | |
| SCHEMBL16549751 | 0.69 | KMT2A (0.39) | MAPTRAB9AALDH1A1POLBMEN1 | |
| SCHEMBL16676666 | 0.69 | KMT2A (0.40) | MAPTRAB9AALDH1A1POLBMEN1 | |
| Iodide SCHEMBL1243530 | 0.68 | INSR (0.53) | INSRMAPTRAB9APOLBMAPK1 | |
| SCHEMBL16144029 | 0.68 | INSR (0.51) | INSRMAPTALDH1A1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7727287-B2 | Hemicyanin styryl thiol/disulfide dye, composition comprising hemicyanin styryl thoil/disulfide dye, and method for lightening keratin materials using hemicyanin styryl thiol/disulfide dye | L'OREAL S.A. (FR) | 2010-06-01 | — | — | US | disclosed |
| US-20090211038-A1 | HEMICYANIN STYRYL THIOL/DISULFIDE DYE, COMPOSITION COMPRISING HEMICYANIN STYRYL THIOL/DISULFIDE DYE, AND METHOD FOR LIGHTENING KERATIN MATERIALS USING HEMICYANIN STYRYL THIOL/DISULFIDE DYE | L'OREAL S.A. (FR) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090211038-A1 | HEMICYANIN STYRYL THIOL/DISULFIDE DYE, COMPOSITION COMPRISING HEMICYANIN STYRYL THIOL/DISULFIDE DYE, AND METHOD FOR LIGHTENING KERATIN MATERIALS USING HEMICYANIN STYRYL THIOL/DISULFIDE DYE | KRT18, SCNN1B, TST | INSR 4743/4885MAPT 764/4885RAB9A 4381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.